Anti-SMG9 monoclonal antibody

Pre-made anti-SMG9 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SMG9/SMG9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1760-Ab-1/ GM-Tg-hg-IP1760-Ab-2Anti-Human SMG9 monoclonal antibodyHuman
GM-Tg-rg-IP1760-Ab-1/ GM-Tg-rg-IP1760-Ab-2Anti-Rat SMG9 monoclonal antibodyRat
GM-Tg-mg-IP1760-Ab-1/ GM-Tg-mg-IP1760-Ab-2Anti-Mouse SMG9 monoclonal antibodyMouse
GM-Tg-cynog-IP1760-Ab-1/ GM-Tg-cynog-IP1760-Ab-2Anti-Cynomolgus/ Rhesus macaque SMG9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1760-Ab-1/ GM-Tg-felg-IP1760-Ab-2Anti-Feline SMG9 monoclonal antibodyFeline
GM-Tg-cang-IP1760-Ab-1/ GM-Tg-cang-IP1760-Ab-2Anti-Canine SMG9 monoclonal antibodyCanine
GM-Tg-bovg-IP1760-Ab-1/ GM-Tg-bovg-IP1760-Ab-2Anti-Bovine SMG9 monoclonal antibodyBovine
GM-Tg-equg-IP1760-Ab-1/ GM-Tg-equg-IP1760-Ab-2Anti-Equine SMG9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1760-Ab-1/ GM-Tg-hg-IP1760-Ab-2; GM-Tg-rg-IP1760-Ab-1/ GM-Tg-rg-IP1760-Ab-2;
GM-Tg-mg-IP1760-Ab-1/ GM-Tg-mg-IP1760-Ab-2; GM-Tg-cynog-IP1760-Ab-1/ GM-Tg-cynog-IP1760-Ab-2;
GM-Tg-felg-IP1760-Ab-1/ GM-Tg-felg-IP1760-Ab-2; GM-Tg-cang-IP1760-Ab-1/ GM-Tg-cang-IP1760-Ab-2;
GM-Tg-bovg-IP1760-Ab-1/ GM-Tg-bovg-IP1760-Ab-2; GM-Tg-equg-IP1760-Ab-1/ GM-Tg-equg-IP1760-Ab-2
Products NameAnti-SMG9 monoclonal antibody
Formatmab
Target NameSMG9
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SMG9 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1760-Ag-1Recombinant multi-species SMG9/ C19orf61/ F17127_1 protein


    Target information

    Target IDGM-IP1760
    Target NameSMG9
    Gene ID56006,71997,365215,710940,476444,101090729,615492,100070296
    Gene Symbol and Synonyms1500002O20Rik,C18H19orf61,C19orf61,F17127_1,HBMS,NEDITPO,RGD1309888,SMG9
    Uniprot AccessionQ9H0W8,Q5PQS6,Q2YDD2
    Uniprot Entry NameSMG9_HUMAN,SMG9_RAT,SMG9_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000105771
    Target ClassificationN/A

    The target: SMG9, gene name: SMG9, also named as C19orf61, F17127_1, HBMS. This gene encodes a regulatory subunit of the SMG1 complex, which plays a critical role in nonsense-mediated mRNA decay (NMD). Binding of the encoded protein to the SMG1 complex kinase scaffold protein results in the inhibition of its kinase activity. Mutations in this gene cause a multiple congenital anomaly syndrome in human patients, characterized by brain malformation, congenital heart disease and other features. [provided by RefSeq, Jul 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.